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Abstract
Objective: to evaluate the safety and tolerability of Tilt Testing (TT) and Carotid Sinus Massage (CSM) in octogenarians with
unexplained syncope.
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Methods: patients consecutively referred for transient loss of consciousness to the ‘Syncope Units’ of three hospitals were en-
rolled. TT and CSM were performed according to the European Society of Cardiology guidelines on syncope. Complications
were evaluated in each group. An early interruption of TT was defined as ‘intolerance’ and considered as a non-diagnostic
response.
Results: one thousand four hundred and one patients were enrolled (mean age 72 ± 16 years, male 40.8%). Six hundred and
ninety-four patients (49.5%) were 80 years old or older (mean age 83 ± 3 years) and 707 (50.5%) were younger (mean age
60 ± 17 years). Complications after TToccurred in 4.5% of older patients and in 2.1% of the younger ones (P = 0.01). All com-
plications were ‘minor/moderate’, as prolonged hypotension, observed in 3% of patients ≥80 years. Major complications
such as sustained ventricular tachycardia, ventricular fibrillation, asystole requiring cardiac massage, transient ischaemic attack,
stroke and death were not observed in any patient. The presence of orthostatic hypotension and the mean number of syncopal
episodes were predictors of TT complications. Intolerance was reported in 2.4% of older patients and 1% of the younger ones
(P= 0.08), mainly due to orthostatic intolerance. No complications occurred after CSM.
Conclusions: TT and CSM appear to be safe and well tolerated in octogenarians, who should not be excluded by age from the
diagnostic work-up of syncope.
Keywords: Safety, Tilt Table Test, Carotid sinus syncope, octogenarian, older people
Introduction
Syncope is common in older people [1], with a dramatic age
gradient peaking in adults over 70 years, for whom the diag-
nostic assessment can be complex. In the first instance, an
accurate history may not be available from the patient and a
witness account is also not infrequently unavailable [2].
Moreover, a prodrome may be absent or, if present, it is often
of mild intensity, of short duration and poorly specific or atyp-
ical [3]. Finally, older patients frequently experience retrograde
amnesia and are unable to recall loss of consciousness [4].
Therefore, Tilt Testing (TT) and Carotid Sinus Massage
(CSM) represent important objective diagnostic tests in older
patients with syncope. It has been previously demonstrated in
a number of small cohort studies that TT and CSM are safe
and well tolerated in the elderly [5–10], but there are no
large-scale reports about their safety in octogenarians, which
will be highly relevant given the projected global increase in
the number of these patients. The aim of the present study is
to assess TT and CSM safety and tolerability in octogenarians
and to identify predictors of complications.
Methods
This is a prospective study carried out in 1,401 patients
consecutively referred for investigation of transient loss of
consciousness to the ‘Syncope Unit’ of three different hospi-
tals (Modena, Florence and Dublin). All were investigated as
per the European Society of Cardiology (ESC) guidelines on
syncope [11], which initial assessment included detailed
history, physical examination, 12-lead electrocardiogram
(ECG), orthostatic blood pressure (BP) measurements; all
patients underwent TT and CSM, because of unexplained
syncope after initial evaluation.
The medical assessment included details of co-morbidities
(diabetes, hypertension, varicose veins, heart disease), medica-
tions (in particular antiarrhythmic, anticonvulsant and hypoten-
sive drugs) and characteristics of the spontaneous episodes
(number, prodrome, injuries, predisposing factors and situa-
tions). Angiotensin-converting enzyme inhibitors (ACEi), angio-
tensin receptor blockers (ARB), β-blockers, α-receptor blockers,
α-receptor agonists, calcium channel blockers, nitrates, diuretics,
benzodiazepines and antidepressants were considered as drugs
with definite or potential hypotensive effect. Left and right
bundle branch block, anterior or posterior fascicular block,
first-degree atrio-ventricular block and bifascicular block were
considered as pathological ECG findings. TT and CSM were
performed when the cardiological investigation was negative.
Orthostatic hypotension was defined as a decrease in systolic
BP ≥20 mmHg and in diastolic BP ≥10 mmHg during 3-min
active stand.
TT was performed according to the Italian Protocol [12],
previously validated in older patients [6]. After 5 min of
supine rest, patients in fasting state and after having taken the
usual therapy were tilted up to 60° on a tilt table with foot-
plate support. If syncope did not occur within 20 min, the
test was potentiated with the administration of sublingual
nitroglycerine (GNT) (400 µg Natispray), and the observa-
tion was prolonged for additional 15 min. Neurally mediated
syncope was defined according to the VASIS classification
(Vasovagal Syncope International Study) [13]. A slow and
progressive decrease in BP, generally without (or only mild)
increase in heart rate, leading to the development of symp-
toms was defined as ‘disautonomic response’. An ‘exagger-
ated response’ was defined as a gradual development of
symptoms (milder than spontaneous ones) associated with a
slow (>5 min) decrease in BP, generally with an increase in
heart rate, during the pharmacological phase [14]. To reduce
the diurnal autonomic variability, TT was performed
between 8:30 and 10:30 am, in a quiet environment, dim
lighted and temperate. Severe aortic or mitral valve stenosis
and myocardial infarction in the 8 weeks before were contra-
indications to TT.
CSM was performed according to the ‘Method of symp-
toms’ [15]. Transient ischaemic attack or stroke in the 3
months before, or critical carotid artery stenosis at Doppler
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ultrasonography, performed in the presence of carotid bruits,
was contraindications to the CSM [16].
TT and CSM were performed under continuous ECG and
systemic beat-to-beat BP monitoring. BP was continuously
monitored with an appropriate size finger cuff, and the hand
was supported with a sling to keep the finger at the heart level.
A written informed consent to perform the neuroauto-
nomic evaluation and to participate in a research study was
obtained from each patient.
Complications during TT and CSM were prospectively
recorded in all patients. Potential complications of TT and CSM
were predefined and classified as follows: minor/moderate:
prolonged hypotension (with or without fluid administration),
prolonged bradycardia requiring atropine administration, atrial
fibrillation (AF) or other supraventricular tachyarrhythmias,
non-sustained ventricular tachycardia (nsVT), and major: pro-
longed asystole requiring cardiac massage, sustained VT (sVT),
ventricular fibrillation (VF), transient ischaemic attack (TIA),
stroke, death. Minor signs/symptoms not secondary to the
vasovagal reaction were also recorded. An early interruption of
TT, due to difficulty in maintaining the tilt position, anxiety,
poor compliance or symptoms not related to changes in BP
or HR, was defined as ‘intolerance’ and considered as a non-
diagnostic response. Causes of intolerance were recorded in
both the age groups.
Declaration of sources of funding
This work was supported by Cassa di Risparmio di Pistoia
and Pescia Foundation. The funding source had no role in
the design and conduct of the study, collection, management,
analysis and interpretation of the data, preparation, review or
approval of the manuscript and decision to submit the
manuscript for publication.
Statistical analysis
All analyses were performed using Statistica version 8.0
(StatSoft Italia, Padova, Italy) and SPSS version 12.2 (SPSS
Inc., Chicago, IL, USA). The χ2 test was used to compare di-
chotomous variables between groups, and the Student t-test
for unpaired data was used to compare continuous data with
normal distribution. The data are reported as the mean ±
standard deviation or as a percentage. Moreover, a multivari-
ate analysis of predictors of different diagnoses and compli-
cations was performed by multiple logistic regression. The
hazard ratio (HR) was provided with its 95% confidence
interval (CI). P < 0.05 was considered to be statistically sig-
nificant. The study population was divided by age in two
groups (<80 and ≥80 years old).
Results
Study population
One thousand four hundred and one consecutive patients were
enrolled; the mean age was 72 ± 16.8 years (age range 15–95;
median age 79 years; inter-quartile range 67–83); 694 patients
(49.5%) were aged ≥80 (mean age 83.6 ± 3.1 years) and 707
patients (50.5%) were younger (mean age 60.7 ± 17.1 years).
The characteristics of the population are listed in Table 1.
Older patients had higher co-morbidity rate. Younger
patients reported a higher number of syncopal episodes
(4.8 ± 6.9 versus 3.7 ± 5.2, P = 0.002), whereas unexplained
falls were more frequent in older patients (32.6 versus 12%,
P< 0.0001). Orthostatic hypotension was present in 458
patients (32.7%), with a higher prevalence in older patients
(46.7 versus 18.9%, P < 0.0001). The 59.6% of the patients
was taking anti-hypertensive drugs, (73.5% of older patients
versus 46% of the younger ones, P < 0.0001).
TT and CSM responses
The neuroautonomic evaluation was positive in 852 patients
(60.8%), with a similar positivity rate in the two groups
(59.7% in younger and 62% in older patients, P = 0.4).
TT was positive in 692 patients (49.4%, respectively,
46.3% in the older and 52.5% in the younger group,
P= 0.02). The cardio-inhibitory and the mixed response
(both cardio-inhibitory and vasodepressive) were more
common in younger patients, whereas vasodepressive and
dysautonomic responses were more frequent in older
patients (data not shown). An exaggerated response was
observed in 61 patients (4.4%), with a similar rate in the two
groups (4% in younger versus 4.8% in older patients,
P= 0.5). At multivariate analysis, a positive response to TT
was associated with the presence of prodromes (HR 0.88,
CI 0.83–0.94, P = 0.0001) and syncope related to predispos-
ing conditions (HR 0.92, CI 0.88–0.98, P = 0.009), whereas
pacemaker (HR 0.91, CI 0.87–0.97, P = 0.003) and chronic
therapy with nitrates (HR 1.10, CI 1.04–1.17, P= 0.002)
were associated with a lower TT positivity rate.
CSM was positive in 147 patients (10.5%), without dif-
ferences in the two groups (9.6% in younger and 11.4% in
older patients, P = 0.3). Ninety-five patients (64.6%) had
cardio-inhibitory Carotid Sinus Syndrome (CSS), 33 had
vasodepressive CSS (22.5%) and 19 had mixed CSS (12.9%),
with a similar distribution in the two groups. Carotid Sinus
Hypersensitivity (CSH) was present in 107 patients (7.6%):
among these, 55 were older (7.9%) and 52 were younger
(7.4%), P = 0.7. At multivariate analysis, advanced age (HR
1.07, CI 1.01–1.14, P = 0.003) and male sex (HR 1.14, CI
1.07–1.20; P= 0.04) were predictors of positive response.
Complications during CSM and TT
No minor/moderate or major complications occurred
during or after the CSM.
Complications after TTwere observed in 46 patients (3.3%)
and were more prevalent in the older group: 15 younger
patients (2.1%) and 31 older patients (4.5%, P= 0.01) showed
complications. Complications are reported in Table 2.
The prevalence of minor/moderate complications was
higher in the older group: 15 younger patients (2.1%) and 30
older patients (4.3%) (P= 0.01) showed minor/moderate
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complications. Only prolonged hypotension requiring fluid
administration was more prevalent in the older group (2.2
versus 0%, P = 0.02). The prevalence of prolonged bradycar-
dia requiring atropine administration, AF and nsVTwas very
low and similar in the two groups.
Minor signs/symptoms were present in 10 patients aged
<80 (1.4%) and in 8 patients aged ≥80 (1.2%, P = 0.95); they
included nausea and/or vomiting requiring anti-emetic
drugs in 10 patients, flushing in one patient, persistent brady-
cardia that did not require atropine or pacing in two patients,
frequent ventricular extrasystoles in three patients, short self-
limiting atrial tachycardia in one patient and chest pain,
without pathological ECG findings, in one patient.
A 87-year-old patient developed a self-limited expressive
dysphasia, which was considered as a transient ischaemic event
and recorded among major complications. Three patients
(0.2%) were referred to the Emergency Department because of
AF (two patients), chest pain (not associated with pathologic
ECG findings), with no differences between the two age
groups (0.3% in younger patients versus 0.1% in the older ones,
P= 0.612).
Patients with complications had a higher mean age
(77.2 ± 12.1 versus 71.8 ± 16.9 years, P = 0.03) and showed
more frequent venous incompetence (47.8 versus 31.1%,
P = 0.02) and orthostatic hypotension (50 versus 32.1%,
P = 0.01); moreover, they reported a higher number of syn-
copal episodes (7.1 ± 8.2 versus 4.2 ± 6.0, P = 0.001), anter-
ior fascicular block (17.4 versus 6%, P = 0.002) and
bi-fascicular block (10.9 versus 3.7%, P = 0.01) (Table 3).
At multivariate analysis, the mean number of syncopal
episodes (HR 1.10, CI 1.04–1.16, P = 0.01) and the presence
of orthostatic hypotension (HR 1.06, CI 1.01–1.13, P= 0.03)
were predictors of TT complications, whereas the age was
not related to the occurrence of complications.
Intolerance to TT was observed in 24 patients (1.7%),
including 17 older patients (2.4%) and 7 younger subjects
(1%, P= 0.08).
Discussion
The main finding of this study is that major complications
such as sVT, VF, TIA, stroke and death were not observed in
patients ≥80 years during TT and CSM. Only prolonged
hypotension, requiring fluid administration in most cases,
was more frequent in patients aged 80 or older, even if in a
low percentage of cases (3%).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Characteristics of the population
All patients (n= 1,401) Age < 80 years (n= 707) Age ≥ 80 years (n= 694) P-value
Mean age (years ± SD) 72.0 ± 16.8 60.7 ± 17.1 83.6 ± 3.1 <0.0001
Number of syncope (mean ± SD) 4.3 ± 6.1 4.8 ± 6.9 3.7 ± 5.2 0.002
Male/Female (n) 571/830 331/376 240/454 <0.0001
Hypertension, n (%) 846 (60.4) 325 (45.9) 521 (75.1) <0.0001
Diabetes, n (%) 207 (14.8) 91 (12.9) 116 (16.7) 0.04
History of falls, n (%) 311 (22.2) 85 (12.0) 226 (32.6) <0.0001
Orthostatic hypotension, n (%) 458 (32.7) 134 (18.9) 324 (46.7) <0.0001
Heart disease, n (%) 324 (23.1) 115 (16.3) 209 (30.1) <0.0001
Varicose veins, n (%) 443 (31.6) 140 (19.8) 303 (43.7) <0.0001
Presyncope, n (%) 480 (34.3) 268 (37.9) 212 (30.6) 0.004
Prodromes, n (%) 885 (63.2) 510 (72.1) 375 (54.0) <0.0001
Situational syncope, n (%) 429 (30.6) 245 (34.7) 184 (26.5) 0.001
Injuries, n (%) 560 (40.0) 237 (33.5) 323 (46.5) <0.0001
Hypotensive drugs, n (%) 835 (59.6) 325 (46.0) 510 (73.5) <0.0001
ACEi/ARB, n (%) 636 (45.4) 244 (34.5) 392 (56.5) <0.0001
β-blockers, n (%) 195 (13.9) 75 (10.6) 120 (17.3) 0.0003
Calcium channel antagonists, n (%) 220 (15.7) 84 (11.9) 136 (19.6) <0.0001
Alpha-receptor blockers, n (%) 121 (8.6) 38 (5.4) 83 (12.0) <0.0001
Alpha-receptor agonists, n (%) 12 (0.9) 6 (0.9) 6 (0.9) 0.9
Nitrates, n (%) 99 (7.1) 31 (4.4) 68 (9.8) <0.0001
Diuretics, n (%) 336 (24.0) 116 (16.4) 220 (31.7) <0.0001
Antiarrhythmic, n (%) 80 (5.7) 35 (4.9) 45 (6.5) 0.2
Antiepileptics, n (%) 73 (5.2) 39 (5.5) 34 (4.9) 0.6
Antidepressants, n (%) 268 (19.1) 98 (13.9) 170 (24.5) <0.0001
Benzodiazepines, n (%) 186 (13.3) 77 (10.9) 109 (15.7) 0.008
Pathologic ECG, n (%) 400 (28.6) 134 (18.9) 266 (38.3) <0.0001
Left bundle branch block, n (%) 52 (3.7) 16 (2.3) 36 (5.2) 0.004
Right bundle branch block, n (%) 87 (6.2) 37 (5.2) 50 (7.2) 0.1
Anterior fascicular block, n (%) 89 (6.4) 28 (4.0) 61 (8.8) 0.0002
First-degree AV block, n (%) 100 (7.1) 30 (4.2) 70 (10.1) <0.0001
Bifascicular block, n (%) 55 (3.9) 19 (2.7) 36 (5.2) 0.02
Pacemaker, n (%) 60 (4.3) 21 (3.0) 39 (5.6) 0.01
SD, standard deviation; ACEi, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; ECG, electrocardiogram; AV, atrio-ventricular.
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The present study demonstrates that TT and CSM are
safe and well-tolerated in octogenarians in a large sample of
patients evaluated for suspected syncope according to the
protocol proposed by the ESC guidelines on syncope [11].
TT was positive in 49.4% of patients. TT positivity rate
was higher in younger patients (52.5 versus 46.3%, P = 0.02),
as shown in a recent meta-analysis [17], whereas venous in-
competence and orthostatic hypotension were more frequent
in older patients, suggesting a tendency to orthostatic rather
than vasovagal syncope with advancing age; orthostatic
hypotension is indeed the first cause of syncope in older
patients [7]. The vasodepressive response was the most fre-
quent in the entire sample (58.5%) and more common in older
patients, whereas the cardio-inhibitory response was more
frequent in the younger ones, according to previous studies
[14, 18, 19]. This difference may be due to an age-related
decline in the vagal drive to the heart or to reduced susceptibil-
ity of the parasympathetic receptors [20]. Multivariate analysis
showed that TT positivity was related to a positive history for
predisposing factors or conditions and prodromes; chronic
therapy with nitrates was associated with a lower TT positivity
rate, maybe because the drug tolerance induced by nitrates
could interfere with the nitroglycerine administered during the
test, reducing or nullifying its effects [21].
CSM was positive in 147 patients (10.5%), showing a
cardio-inhibitory response in the 64.6% of the cases. Our in-
cidence of CSS was similar to what previously found in the
general population and in older people [7, 22].
Complications related to TT occurred rarely (3.3% of the
patients), more frequently in older patients (4.5 versus 2.1%,
P= 0.01); one of the complications was major (transient dys-
phasia in a 87-year-old patient), whereas the majority of com-
plications was minor/moderate, consisting mainly in prolonged
hypotension. Prolonged hypotension could be an expression of
sympathetic dysfunction; in this regard, orthostatic hypotension
and a high number of syncopal episodes were predictors of
complications.
Gieroba et al. [10] previously evaluated the safety of TT in
patients aged 60 and older, including a large number of patients
with cardiovascular and cerebrovascular co-morbidities. The
study population was divided by age in two groups (<75 and
≥75 years old) and 1,969 procedures were performed; of
these, 1,495 (76%) were unprovoked TT and 474 (24%) were
GNT-provoked TT (GNT 800 µg). The results of the study
showed that TT is safe in patients aged 75 and older.
According to the Literature, cardiac arrhythmias are rarely
reported after CSM [8, 23–25], and the incidence of neuro-
logical complications is low (0.17–0.45%) [15, 16, 26]. In our
population, no complications occurred after the ‘10 s pro-
cedure’, indicating that this test can be safely performed in
octogenarians, as well as the ‘5 s procedure’ evaluated by
Walsh et al. [8] in a large population of elderly. In our re-
search, all the patients were evaluated for carotid stenosis
through the auscultation of the carotid arteries and a vessels
ultrasound in case of carotid bruit. Since no neurological
complications occurred, our study confirms that this proto-
col is safe, in accordance to Richardson et al. [27].
Intolerance was observed only in 24 patients (1.7%), with a
similar rate in the two age groups (2.4 versus 1%, P= 0.08).
The early interruption of the test was mainly due to orthostatic
intolerance (inability to maintain the upright position), as
reported by Paling et al. in a smaller population [9]. Some
authors believe that shortened protocols may improve tolerabil-
ity, particularly in older patients who are unable to tolerate pro-
longed upright posture due to physical frailty or medical
problems (back pain, neurologic deficits, etc.). Macedo et al. [28]
and Parry et al. [29] have analysed protocols without the passive
phase, which proved to be not inferior to conventional TT and
unprovoked TT, respectively. Bartoletti et al. [30] previously
evaluated a similar protocol with a 5-min passive phase report-
ing a lower positivity rate; therefore, more studies are needed to
assess the role of shortened protocols in frail patients.
Limitations
The specificity of TT has not been adequately investigated in
patients ≥80 years; therefore, its diagnostic value in this age
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Tilt testing complications
All patients (n= 1,401) Age < 80 years (n= 707) Age ≥ 80 years (n= 694) P-value
Minor/moderate complications, n (%) 45 (3.3) 15 (2.1) 30 (4.5) 0.01
Minor signs/symptoms, n (%) 18 (1.4) 10 (1.4) 8 (1.3) 0.952
Prolonged hypotension, n (%) 6 (0.4) 2 (0.3) 4 (0.6) 0.968
Prolonged hypotension requiring fluid administration, n (%) 15 (1.1) 0 (0.0) 15 (2.2) 0.020
Prolonged bradycardia requiring atropine administration, n (%) 2 (0.1) 1 (0.1) 1 (0.1) 0.985
AF, n (%) 3 (0.2) 2 (0.3) 1 (0.1) 0.859
nsVT, n (%) 1 (0.07) 0 (0.0) 1 (0.1) 0.963
Major complications, n (%) 1 (0.07) 0 (0.0) 1 (0.1) 0.963
sVT, n (%) 0 (0.0) 0 (0.0) 0 (0.0) –
VF, n (%) 0 (0.0) 0 (0.0) 0 (0.0) –
Prolonged asystole requiring cardiac massage, n (%) 0 (0.0) 0 (0.0) 0 (0.0) –
TIA, n (%) 1 (0.07) 0 (0.0) 1 (0.1) 0.963
Stroke, n (%) 0 (0.0) 0 (0.0) 0 (0.0) –
Death, n (%) 0 (0.0) 0 (0.0) 0 (0.0) –
AF, atrial fibrillation; nsVT, non-sustained ventricular tachycardia; sVT, sustained ventricular tachycardia; VF, ventricular fibrillation; TIA, transient ischaemic attack.
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group is not very clear. However, the main purpose of this
study was to investigate the safety of TT in octogenarians.
Conclusions
In conclusion, the results of the present study demonstrate,
in a large sample of patients, that TT and CSM are safe and
well tolerated in octogenarians, who should not be excluded
by age from this diagnostic work-up.
Key points
• Our research demonstrates that TT and CSM can be safely
performed in a large sample of patients aged 80 and older.
• Orthostatic hypotension is a predictor of complications,
whereas advanced age is not related to any.
• No previous large studies have evaluated safety and toler-
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